For retatrutide specifically, 12 mg weekly produces the largest loss but has the highest GI dropout rate, and 9 mg weekly gives nearly the same loss with better tolerability
The letter emphasized several key points: Bulk compounding of semaglutide and tirzepatide is no longer permitted because FDA removed these products from the national shortage list Marketing terms such as generic Ozempic, semaglutide pills or vitamin-enhanced GLP-1 injections may violate state consumer-protection law when referring to non-approved formulations Misleading advertising of unapproved GLP-1 products falls under the Connecticut Unfair Trade Practices Act (CUTPA) Although the letter did not accuse any specific provider of wrongdoing, Connecticut placed clinics on formal notice that the GLP-1 market was under review and that enforcement would follow if risky practices continued
If youre not ready to make lifestyle changes, the medications alone wont produce lasting results
The short answer is this: retatrutide looks promising for body composition, but current research does not prove that it directly builds muscle or fully prevents muscle loss
Patients currently using injectable GLP-1 medications should follow the specific administration instructions provided with their prescribed product
The STEP 1 trial (N=1,961) enrolled adults with BMI 30 kg/m (or 27 kg/m with at least one weight-related comorbidity), and participants achieved 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo [6]